A Study to Evaluate the Efficacy, Safety, and Tolerability of SAGE-324 in Participants With Essential Tremor

NCT04305275 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

69

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Tremor

Interventions

DRUG: SAGE-324
DRUG: SAGE-324 Placebo

Sponsor

Sage Therapeutics